Verdemed strives to bring cannabis-based medications to patients in Latin America.
Cannabis has been used as a health treatment throughout most of human history. A number of cultures have taken advantage of its medical properties, and, over the past two decades, the scientific community has increasingly identified these medical attributes.
There are hundreds of peer-reviewed scientific studies recognizing the potential of cannabis-based pharmaceuticals to substantially improve many health conditions. Verdemed’s mission is to realize this potential in Latin America by bringing cutting-edge medication to this area and enabling doctors to improve the treatment of millions of patients.
The endocannabinoid system
It was during the 1960s that THC (tetrahydrocannabinol) and CBD (cannabidiol) were first identified and their structures elucidated. Two decades later, in 1988, scientists were able to locate cannabinoid receptors in an animal’s brain, which THC and CBD bind to. Studies continued in the 1990s and the isolation and cloning of the two known cannabinoid receptors, CB1 and CB2, cast a brighter light on the endocannabinoid system. The research on these receptors led to the discovery of endogenous cannabinoids, such as anandamide, which are produced by the human body and bind to CB1 and CB2.
The endocannabinoid system, which consists of several receptors, ligands, and metabolic enzymes throughout the human body, is involved in many different physiological and pathophysiological processes. Endogenous cannabinoids, such as anandamide, play an essential role in regulating this system. THC and CBD act by substituting for these endogenous cannabinoids and connecting with the receptors, CB1 and CB2.
It has been clinically proven that cannabinoids such as THC and CBD are a safe medicine for major health conditions:
Antiemetic in the treatment of chemotherapy-induced nausea and vomiting
Child epilepsy – treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome
Treatment for chronic pain in adults and as an adjunctive therapy for cancer-related pain
Muscle spasticity treatment for patients with multiple sclerosis
There is also evidence that cannabinoids are effective for patients with:
Anxiety symptoms
Appetite and decreasing weight loss associated with HIV/AIDS
Fibromyalgia
Glaucoma
Sleep disturbances associated with obstructive sleep apnea syndrome
Symptoms of post-traumatic stress disorder (PTSD)
Symptoms of Tourette syndrome